Spero Therapeutics names finance head as CEO; shares down

Spero Therapeutics

14/06/2023 14:43

** Shares of drug developer Spero Therapeutics Inc  SPRO.O 
down 1.2% at $1.7
    ** Co appoints its CFO and treasurer, Satyavrat Shukla, as
its president, CEO, and a board member, effective Aug. 1
    ** Shukla will succeed Ankit Mahadevia, who will become
board chairman
    ** Co has launched a search for its next CFO
    ** Board has appointed Stephen DiPalma as interim CFO and
treasurer, effective Aug. 1
    ** SPRO shares down ~1% YTD
    


 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))